News

Treatment with a protease inhibitor plus raltegravir was found to offer no benefit over a protease inhibitor plus nucleoside reverse-transcriptase inhibitor regimen in patients with HIV.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

World Toilet Day, November 9th, is dedicated to promoting awareness and inspiring action against the global sanitation crisis.

What microbial growth was found after Contagion® writer, Saskia Popescu swabbed & sent her samples?

The results of a new study suggest that naturally-acquired immunity against the Zika virus may already occur in women in endemic regions of the world.

A testing stewardship effort found that using a “hard stop” alert system may help reduce inappropriate C. difficile testing.

A research team has found that an antiviral drug available in Russia and a few other countries shows promising results when it comes to fighting Ebola virus disease.

Researchers are gaining a greater understanding of the role that human genetics plays in determining who contracts tuberculosis as well as how severely it impacts its victims.

A recent study seeks to determine if the combination of minocycline with colistin could decrease the incidence of acute renal failure in those treated.

At a recent event called "The Next Pandemic," researchers agreed that the world is not ready for the next big flu pandemic and discussed what it will take to strengthen preparedness.

Congress has requested more information about how government agencies are currently using predictive modeling and simulation technologies to assess the country’s risk for outbreaks and prepare responses.

Researchers have found that human papillomavirus (HPV) vaccine may also protect against recurrent respiratory papillomatosis, a rare, but incurable childhood respiratory disease.

Clinicians should counsel individuals with HIV on avoiding health-related behaviors that may alter their gut microbiota and instead practices those that may decrease inflammation.

The FDA has approved the first sensor-equipped pill capable of digitally tracking whether patients are adhering to their prescribed medications.

The results of a new study may provide a basis for estimating appropriate dosing regimens of ceftolozane/tazobactam in patients with cystic fibrosis.

A recent outbreak of Legionnaires’ disease at Disneyland in Anaheim, California, shows that even the “happiest place on earth” isn’t immune to this virulent pathogen.

As the hepatitis A outbreak in San Diego continues, officials focus their efforts on homeless encamped along the San Diego River. Is the situation improving or getting worse?

A new study suggests that village clinics are not properly dealing with the ongoing problem of tuberculosis in rural China.

With 264 vaccines in the pipeline in the United States, the future for the prevention of diseases appears to be extremely bright.

Hospital employees are increasingly using hospital infection rates to highlight gaps in training, education, and staffing.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Studies have proven that undetectable levels of HIV mean an individual cannot transmit the virus to someone else. Now the word needs to spread.

Researchers from the Ohio State University Wexner Medical Center have found that special electric bandages can disrupt biofilm infection and enable healing in already infected burn wounds.

The vaccine is the only 2-dose regimen for the prevention of infection by all known subtypes of hepatitis b in adults 18 and older.

In a new study, a pair of Australian virologists argue that we cannot predict virus outbreaks, looking at the “fault lines” of interaction between humans and animals may help us be better prepared.

PREVYMIS, or letermovir, has just received approval from the US Food and Drug Administration (FDA) to be administered orally via once-daily tablets and through injection for intravenous use.

In a story that could be straight out of the 1980s, health officials in the state of West Virginia have stated they are dealing with a major outbreak of HIV infections in the southern part of the state.

Two new studies highlight just why the flu vaccine isn’t working and one new approach that may give way to a universal vaccine.